Soy supplement tested to curb asthma in high-risk infants
NCT ID NCT05667701
First seen Nov 21, 2025 · Last updated May 15, 2026 · Updated 22 times
Summary
This study tests whether a soy supplement (isoflavones) can reduce asthma risk in infants who have a genetic tendency for inflammation. 65 babies under 12 months old will receive either soy or a placebo mixed into food for 7 months. Researchers will track wheezing episodes and lung function to see if the supplement helps control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA IN CHILDREN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ann and Robert H Lurie Childrens Hospital of Chicago
RECRUITINGChicago, Illinois, 60611, United States
Contact
Contact Phone: •••-•••-••••
Contact
-
Northwestern University Feinberg School of Medicine
RECRUITINGChicago, Illinois, 60611, United States
Contact
Conditions
Explore the condition pages connected to this study.